Skip to content

BioLife Solutions BLFS Free cash flow

Free cash flow at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$816M+126%
Danaher logo
DanaherDHR
$1.09B+2.9%
Azenta logo
AzentaAZTA
$6.11M-12.7%
LeMaitre Vascular logo
LeMaitre VascularLMAT
$12.31M+60.8%
Haemonetics logo
HaemoneticsHAE
$53.28M-47.2%
TEC
Bio-TechneTECH

Other financials

Income statement

See full
Revenue$27.5M+24.7%
Gross profit$17.5M+18.2%
Operating income$27.0K+105%
Net income$1.2M+365%
EPS (diluted)$0.02

Balance sheet

See full
Cash & equivalents$22.8M-65.9%
Total debt$17.4M-35.6%
Total equity$372.2M+5.6%
Total assets$400.9M+1.5%

Cash flow

See full
Operating cash flow-$491.0K-128%
CapEx$167.0K-4.6%

Valuation

See full
Market cap$1.25B-14.0%
Enterprise value$1.24B-11.2%
P/S12.5×-6.0×

Profitability

See full
Gross margin66.9%
Operating margin-16.7%
Net margin-68.7%
FCF margin-15.9%+18.7pp

Returns & leverage

See full
Return on equity-14.5%-4.7pp
Debt / equity0.0×
Current ratio7.3×+2.6×

Where this comes from

Calculated from BioLife Solutions’s reported figures.

The official record: BioLife Solutions’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioLife Solutions's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioLife Solutions's free cash flow?
BioLife Solutions (BLFS) reported free cash flow of -$658K in Q1 2026.
How has BioLife Solutions's free cash flow changed year-over-year?
BioLife Solutions's free cash flow decreased by 142.4% year-over-year, from $1.55M to -$658K.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.